|
1
|
Li S, Young KH and Medeiros LJ: Diffuse
large B-cell lymphoma. Pathology. 50:74–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz
AD and Jaffe ES: The 2016 revision of the World Health Organization
classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chapuy B, Stewart C, Dunford AJ, Kim J,
Kamburov A, Redd RA, Lawrence MS, Roemer MS, Li AJ, Ziepert M, et
al: Molecular subtypes of diffuse large B cell lymphoma are
associated with distinct pathogenic mechanisms and outcomes. Nat
Med. 24:679–690. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Lisio L, Martinez N, Montes-Moreno S,
Piris-Villaespesa M, Sanchez-Beato M and Piris MA: The role of
miRNAs in the pathogenesis and diagnosis of B-cell lymphomas.
Blood. 120:1782–1790. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng B, Xi Z, Liu R, Yin W, Sui Z, Ren B,
Miller H, Gong Q and Liu C: The Function of MicroRNAs in B-cell
development, lymphoma, and their potential in clinical practice.
Front Immunol. 9:9362018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Costinean S, Zanesi N, Pekarsky Y, Tili E,
Volinia S, Heerema N and Croce CM: Pre-B cell proliferation and
lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155
transgenic mice. Proc Natl Acad Sci USA. 103:7024–7029. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mihailovich M, Bremang M, Spadotto V,
Musiani D, Vitale E, Varano G, Zambelli F, Mancuso FM, Cairns DA,
Pavesi G, et al: miR-17-92 fine-tunes MYC expression and function
to ensure optimal B cell lymphoma growth. Nat Commun. 6:87252015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song G, Gu L, Li J, Tang Z, Liu H, Chen B,
Sun X, He B, Pan Y, Wang S and Cho WC: Serum microRNA expression
profiling predict response to R-CHOP treatment in diffuse large B
cell lymphoma patients. Ann Hematol. 93:1735–1743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Troppan K, Wenzl K, Pichler M, Pursche B,
Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C,
Neumeister P and Deutsch A: miR-199a and miR-497 are associated
with better overall survival due to increased chemosensitivity in
diffuse Large B-cell lymphoma patients. Int J Mol Sci.
16:18077–18095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Babar IA, Cheng CJ, Booth CJ, Liang X,
Weidhaas JB, Saltzman WM and Slack FJ: Nanoparticle-based therapy
in an in vivo microRNA-155 (miR-155)-dependent mouse model of
lymphoma. Proc Natl Acad Sci USA. 109:E1695–E1704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun MM, Li JF, Guo LL, Xiao HT, Dong L,
Wang F, Huang FB, Cao D, Qin T, Yin XH, et al: TGF-β1 suppression
of microRNA-450b-5p expression: A novel mechanism for blocking
myogenic differentiation of rhabdomyosarcoma. Oncogene.
33:2075–2086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun M, Huang F, Yu D, Zhang Y, Xu H, Zhang
L, Li L, Dong L, Guo L and Wang S: Autoregulatory loop between
TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma
modulates proliferation and differentiation. Cell Death Dis.
6:e18592015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo L, Fu J, Sun S, Zhu M, Zhang L, Niu H,
Chen Z, Zhang Y, Guo L and Wang S: MicroRNA-143-3p inhibits
colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer
Sci. 110:805–816. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu YC, Chang JT, Chan EC, Chao YK, Yeh TS,
Chen JS and Cheng AJ: miR-196, an emerging cancer biomarker for
digestive tract cancers. J Cancer. 7:650–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen C, Zhang Y, Zhang L, Weakley SM and
Yao Q: MicroRNA-196: Critical roles and clinical applications in
development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suh YE, Raulf N, Gaken J, Lawler K, Urbano
TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M:
MicroRNA-196a promotes an oncogenic effect in head and neck cancer
cells by suppressing annexin A1 and enhancing radioresistance. Int
J Cancer. 137:1021–1034. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang F, Tang J, Zhuang X, Zhuang Y, Cheng
W, Chen W, Yao H and Zhang S: MiR-196a promotes pancreatic cancer
progression by targeting nuclear factor kappa-B-inhibitor alpha.
PLoS One. 9:e878972014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Popovic R, Riesbeck LE, Velu CS, Chaubey
A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et
al: Regulation of mir-196b by MLL and its overexpression by MLL
fusions contributes to immortalization. Blood. 113:3314–3322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong X, Du Y, Wang G, Gao J, Gong Y, Li L,
Zhang Z, Zhu J, Jing Q, Qin Y and Li Z: Detection of differentially
expressed microRNAs in serum of pancreatic ductal adenocarcinoma
patients: miR-196a could be a potential marker for poor prognosis.
Dig Dis Sci. 56:602–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu YC, Chang JT, Liao CT, Kang CJ, Huang
SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, et al:
OncomiR-196 promotes an invasive phenotype in oral cancer through
the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 13:2182014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Huang S, Wu B, Fang J, Zhu M, Sun
L, Zhang L, Zhang Y, Sun M, Guo L and Wang S: Transforming growth
factor-β1 promotes breast cancer metastasis by downregulating
miR-196a-3p expression. Oncotarget. 8:49110–49122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miao Y, Medeiros LJ, Xu-Monette ZY, Li J
and Young KH: Dysregulation of cell survival in diffuse large B
cell lymphoma: Mechanisms and therapeutic targets. Front Oncol.
9:1072019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilson WH, Young RM, Schmitz R, Yang Y,
Pittaluga S, Wright G, Lih CJ, Williams PM, Shaffer AL, Gerecitano
J, et al: Targeting B cell receptor signaling with ibrutinib in
diffuse large B cell lymphoma. Nat Med. 21:922–926. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu FQ, Zeng L, Tang N, Tang YP, Zhou BP,
Li FF, Wu WG, Zeng XB and Peng SS: MicroRNA-155 downregulation
promotes cell cycle arrest and apoptosis in diffuse large B-cell
lymphoma. Oncol Res. 24:415–427. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan Q, Meng X, Liang H, Zhang H, Liu X, Li
L, Li W, Sun W, Zhang H, Zen K, et al: miR-10a inhibits cell
proliferation and promotes cell apoptosis by targeting BCL6 in
diffuse large B-cell lymphoma. Protein Cell. 7:899–912. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jia YJ, Liu ZB, Wang WG, Sun CB, Wei P,
Yang YL, You MJ, Yu BH, Li XQ and Zhou XY: HDAC6 regulates
microRNA-27b that suppresses proliferation, promotes apoptosis and
target MET in diffuse large B-cell lymphoma. Leukemia. 32:703–711.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Donaldson JG and Jackson CL: ARF family G
proteins and their regulators: Roles in membrane transport,
development and disease. Nat Rev Mol Cell Biol. 12:362–375. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woo IS, Eun SY, Jang HS, Kang ES, Kim GH,
Kim HJ, Lee JH, Chang KC, Kim JH, Han CW and Seo HG: Identification
of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)
retinamide-induced cell death. Cancer Lett. 276:53–60. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu Q, Ren X, Zhang Y, Fu X, Li Y, Peng Y,
Xiao Q, Li T, Ouyang C, Hu Y, et al: MiR-221-3p targets ARF4 and
inhibits the proliferation and migration of epithelial ovarian
cancer cells. Biochem Biophys Res Commun. 497:1162–1170. 2018.
View Article : Google Scholar : PubMed/NCBI
|
